New chambers designed to provide optimum uniformity for stable environmental conditions
Thermo Scientific Environmental Chambers use a unique airflow system for advanced temperature control.
A new range of 230-volt environmental chambers, designed to provide highly stable environmental conditions, is now available in Europe, Africa, Latin America and the Asia Pacific region.
The newly CE-marked range of Thermo Scientific Environmental Chambers provide temperature control above and below ambient for drug stability testing, shelf-life testing, insect studies or controlled storage. There are two models available in the range: the wide temperature units with humidity (available in 311 L and 821 L) and a heat-only model (available in 821 L) that is tailored for large-scale clinical applications and microbiology. For applications that require close control of a CO2 environment, there’s an optional infrared CO2 package available that can be added to the wide temperature model.
The interior of the environmental chambers is designed for stability. The horizontal laminar airflow system enables ideal temperature uniformity and fast recovery rates, which provide an optimal growth and testing environment, even with large product loads or heat-generating equipment.
The environmental chambers feature a broad temperature range spanning from 0 to 60 degrees Celsius and the relative humidity is easily controlled to meet the needs of different applications. Importantly, the chambers meet certain compliance and regulatory requirements, including international conference on harmonization (ICH) guidelines for drug substance and product storage testing.
“Thermo Fisher Scientific has sold environmental chambers for more than 25 years in the US, and we are thrilled to now introduce this product to Europe,” said Konrad Knauss, global product manager, Thermo Fisher Scientific. “Designed with the end user in mind, this series of environmental chambers is highly flexible and suited to a broad range of application needs, meaning that it fits a laboratory’s needs now as well as in the future.”
The rugged construction of the chambers promotes a long lifespan and provides a flexible and cost-effective solution for researchers. The chambers connect to standard monitoring systems for easy internal and regulatory product documentation and can be supplemented with accessories and options for many specific applications.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance